February 13, 2020 / 7:58 AM / 10 days ago

BRIEF-Diurnal Group Says US FDA Accepts For Review New Drug Application For Alkindi Sprinkle

Feb 13 (Reuters) - Diurnal Group PLC:

* DIURNAL GROUP PLC - US FDA ACCEPTS FOR REVIEW DIURNAL’S NEW DRUG APPLICATION FOR ALKINDI SPRINKLE

* DIURNAL GROUP PLC - PDUFA DATE SET BY FDA, WHICH WOULD BE EARLIEST DATE AT WHICH APPROVAL COULD OCCUR, IS 29 SEPTEMBER 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below